The COVID-19 crisis is causing a surge in interest in ‘virtual trials’ where the bulk of the data is collected using digital technology and often from a patient’s own home, a conference heard.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,